Cellply

CellPly, founded in 2013 by Massimo Bocchi and Roberto Guerrieri and led by CEO Emiliano Spagnolo, is a life sciences company developing immune system analysis tools to enable the rapid and effective development of immunotherapies and cell therapies. Its solutions combine proprietary microfluidic technology, capable of capturing functional and phenotypic information from thousands of single cells, with the automated VivaCyte® analytical instrument, integrating robotic solutions and artificial intelligence for image analysis.